INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 111 filers reported holding INSMED INC in Q1 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $752,450 | +12440.8% | 29,800 | +9833.3% | 0.05% | – |
Q3 2022 | $6,000 | -87.5% | 300 | -87.8% | 0.00% | -100.0% |
Q2 2022 | $48,000 | +2300.0% | 2,452 | +2170.4% | 0.00% | – |
Q1 2022 | $2,000 | -91.7% | 108 | -87.9% | 0.00% | -100.0% |
Q4 2021 | $24,000 | -51.0% | 894 | -41.7% | 0.00% | -66.7% |
Q3 2020 | $49,000 | +1125.0% | 1,534 | +447.9% | 0.01% | +100.0% |
Q1 2020 | $4,000 | -97.5% | 280 | -95.5% | 0.00% | -81.2% |
Q2 2019 | $158,000 | +45.0% | 6,200 | +28.1% | 0.02% | +77.8% |
Q1 2018 | $109,000 | +118.0% | 4,841 | +196.1% | 0.01% | +80.0% |
Q4 2017 | $50,000 | -40.5% | 1,635 | -39.9% | 0.01% | -37.5% |
Q3 2017 | $84,000 | -2.3% | 2,722 | -42.9% | 0.01% | -46.7% |
Q4 2015 | $86,000 | -50.0% | 4,767 | -48.7% | 0.02% | -50.0% |
Q3 2015 | $172,000 | +191.5% | 9,296 | +226.5% | 0.03% | +100.0% |
Q1 2015 | $59,000 | +742.9% | 2,847 | +469.4% | 0.02% | +650.0% |
Q4 2014 | $7,000 | -94.7% | 500 | -92.9% | 0.00% | -93.5% |
Q1 2014 | $133,000 | +291.2% | 7,000 | +250.0% | 0.03% | +82.4% |
Q4 2013 | $34,000 | – | 2,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |